Data matrices were generated by measuring anti-proliferative effects (IC50) of i-CDK9 and JQ1 as a single agent or in combination on both HeLa and H1792, a non-small cell lung cancer cell line with significant MYC amplification (CN = 8). This evidence concerns the gene MYC and non-small cell lung carcinoma.